share_log

Argus Research Maintains Buy on Moderna, Raises Price Target to $230

Benzinga Real-time News ·  Jun 24, 2021 08:47

Argus Research analyst Jasper Hellweg maintains Moderna (NASDAQ:MRNA) with a Buy and raises the price target from $200 to $230.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment